🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness

Recruitingn/aAges 18 Years - anyAllIstituto Auxologico Italiano
NCT06334601 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In the framework of pathophysiological trait in obstructive sleep apnea (OSA) patients, a simplified method is proposed to measure upper airway (UA) collapsibility and muscle responsiveness during wakefulness.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Obstructive Sleep Apnea (OSA) * At home-polygraphy with at least one EEG channel (PSG) reporting moderate-to severe obstructive sleep apnea (apnea-hypopnea index \>14). Exclusion Criteria: * OSA treatment ongoing during two weeks before PSG * Unstable cardio-respiratory disease in the 3 months before enrollment * Subjects in O2 treatment
💊

What it tests

  • Tests of upper airway collapsibility and muscle responsiveness.
📍

Where

1 site
IRCCS Istituto Auxologico Italiano,Ospedale San Luca
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy